Microrna In Disease Regulation

48 researchers across 6 institutions

48 Researchers
6 Institutions
4 Grant PIs
5 High Impact

Researchers investigate the roles of microRNAs (miRNAs) in biological processes and disease development. This work explores how small RNA molecules regulate gene expression at the post-transcriptional level and how their dysregulation contributes to various pathologies, including cancer, cardiovascular disease, and neurological disorders. Studies employ molecular biology techniques, genomics, and bioinformatics to identify and characterize miRNAs involved in cellular differentiation, proliferation, apoptosis, and immune responses. Investigations also focus on the potential of miRNAs as biomarkers for early disease detection and as therapeutic targets for novel treatment strategies.

This research has implications for Arkansas's public health, particularly concerning the prevalence of chronic diseases. Understanding miRNA involvement in conditions like cancer and heart disease can inform the development of diagnostic tools and treatments tailored to the state's demographics. Furthermore, insights into miRNA function may contribute to the state's growing biosciences sector, fostering innovation in biotechnology and pharmaceutical development.

This area of study intersects with cancer biology, molecular mechanisms, pharmacology, and cardiovascular research. Engagement spans multiple Arkansas institutions, with researchers contributing expertise from diverse backgrounds to address complex biological questions.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Yong Zhu UAMS 41 5,411 Grant PI High Impact
Takehiro Nakamura UAMS 41 5,817
Seong Wook Kang University of Arkansas 35 4,848 High Impact
Ruby Charak UAMS 25 2,098
George Hammons NCTR 24 2,037
Lu Dai UAMS 23 1,687 Grant PI High Impact
Pritmohinder S. Gill UAMS 21 2,197 High Impact
Ryan M. Allen UAMS 20 2,253 High Impact
Valentina K. Todorova UAMS 18 805
Vikrant Vijay NCTR 16 1,193
Sandra Stotsky University of Arkansas 15 2,744
Shahzad Bhatti UAMS 15 687
Neha S. Dole UAMS 14 608 Grant PI
Shan Zhao University of Arkansas 13 764
Hoda A. Hagrass UAMS 12 506
Bridgett Knox NCTR 12 416
Subramaniam Ponnappan UAMS 11 580
Haixia Lin UAMS 11 369
Haihong Zhang UAMS 11 440
Graham M. Strub UAMS 10 3,282

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
2 works in 2028
-59.1% CAGR 2018–2028
Leadership concentration
6.5% held by global top 5 institutions
Fragmented HHI 32
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2028 window.

Top US institutions in this area

  1. 1 Harvard University 2,555
  2. 2 The University of Texas MD Anderson Cancer Center 1,707
  3. 3 The Ohio State University 1,360
  4. 4 National Institutes of Health 1,190
  5. 5 Johns Hopkins University 1,164

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Microrna In Disease Regulation.

49%
Shelby Johns University of Arkansas
Ikjae Shin UAMS
40%
Philip H. Williams UA Little Rock
Ikjae Shin UAMS
38%
Tuesday N. Melton Ouachita Baptist University
Nathan S. Reyna Ouachita Baptist University
38%
Ikjae Shin UAMS
Colton Althaber University of Arkansas
35%
Shelby Johns University of Arkansas
34%
Phyllis M. Nelson Ouachita Baptist University
30%
Hongwei Xu UAMS

Researchers with Federal Grants

Browse All 48 Researchers in Directory